Medgenics (MDGN) Misses Q2 EPS by 39c
Tweet
Share
E-mailGet Alerts MDGN Hot Sheet
Join SI Premium – FREE
Medgenics (NYSE: MDGN) reported Q2 EPS of ($0.69), $0.39 worse than the analyst estimate of ($0.30).
For earnings history and earnings-related data on Medgenics (MDGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
- Yum! Brands (YUM) PT Lowered to $180 at Argus
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
